[Cancer of the anal canal].
Gérard
J P
JP
Service de radiothérapie, Centre hospitalier Lyon-Sud, Pierre-Bénite, France.
Romestaing
P
P
Ardiet
J M
JM
Sentenac
I
I
Mahé
M
M
D000230:Adenocarcinoma / Q000532:radiotherapy / Q000628:therapy; D000328:Adult; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001005:Anus Neoplasms / Q000532:radiotherapy / Q000628:therapy; D018196:Carcinoma, Adenosquamous / Q000532:radiotherapy / Q000628:therapy; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy / Q000628:therapy; D002945:Cisplatin / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D008937:Mitomycins / Q000627:therapeutic use; D011879:Radiotherapy Dosage
D000903:Antibiotics, Antineoplastic; D000964:Antimetabolites, Antineoplastic; D008937:Mitomycins; D002945:Cisplatin; D005472:Fluorouracil
Le cancer du canal anal.